Saltar al contenido
Merck

1.41464

SAFC

Parteck® MXP (Polyvinyl alcohol 4-88)

EMPROVE® ESSENTIAL, Ph. Eur., ChP, JPE, USP

Fabricación farmacéutica

Sinónimos:

Parteck® Polyvinyl alcohol, PVA, PVOH

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula lineal:
(C2H4O)n
Número de CAS:
Número MDL:
Código UNSPSC:
13111042
En este momento no podemos mostrarle ni los precios ni la disponibilidad

Agency

ChP
JPE
Ph. Eur.
USP

Nivel de calidad

Línea del producto

EMPROVE® ESSENTIAL

Formulario

fine powder

tamaño de partícula

≤200 μm (d95)

mp

160-240 °C

aplicaciones

controlled release
pharmaceutical
solid formulation
solubility enhancement

temp. de almacenamiento

15-25°C

InChI

1S/C2H4O/c1-2-3/h2-3H,1H2

Clave InChI

IMROMDMJAWUWLK-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Descripción general

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Aplicación

Parteck® MXP excipient is a polyvinyl alcohol-based excipient specifically designed for hot-melt extrusion to increase the solubility of poorly water soluble APIs via stabilization of the amorphous solid state. Parteck® MXP enables stable and high drug loads and can be used for a broad range of poorly water soluble APIs and a variety of final dosage forms.

Características y beneficios

  • Superior supersaturation performance via precipitation inhibition
  • High thermostability up to 250°C, extending the potential application range
  • Stable high drug loads and suitability with a broad range of APIs
  • Flexible release kinetics
  • Compatible with several downstream processing capabilities, like direct compression, continuous manufacturing, thin film extrusion and 3D printing
  • Optimized powder properties for excellent performance in the HME process
  • Suitable polymer properties for HME, spray drying and 3D printing processes

Información legal

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Aplicación

Referencia del producto
Descripción
Precios

Producto relacionado

Referencia del producto
Descripción
Precios

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 1


¿Qué es el programa Emprove®?

El programa Emprove® es un sistema que proporciona documentación completa y exhaustiva de nuestros filtros y componentes de un solo uso, materias primas farmacéuticas y materiales de partida.

Material Qualification Dossier

Gratuito, iniciar sesión para descargar

Quality Management Dossier (Open Access)

Gratuito, iniciar sesión para descargar

Quality Management Dossier (Open Access)

Gratuito, iniciar sesión para descargar

Operational Excellence Dossier

Disponible mediante suscripción o mediante pago de una tarifa.

Más información sobre las ventajas que le puede proporcionar una suscripción al programa Emprove®
¿Por qué no están disponibles estos documentos?
Los expedientes Emprove® contienen información destinada a respaldar el proceso de registro y las actividades de evaluación del riesgo de los productores farmacéuticos y contienen información confidencial. contacte con nosotros si desea tener acceso.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Artículos

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

3D printing can overcome challenges during formulation development, with a focus on enhancing API bioavailability in solid dispersions. Find out how in this technical article.

Ver todo

Contenido relacionado

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

For selective laser sintering (SLS) polymers are needed for a successful workflow and selection of the best approach requires consideration of several factors.

Questions

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico